^
BIOMARKER:
ER mutation
i
Other names: ESR1, Era, ESR, NR3A1, ER, ER beta
Entrez ID:
ER mutation
Estrogen Receptor Positive Breast Cancer
bevacizumab + paclitaxel
Sensitive
:
C3
ESMO-BC 2021 - 1wk
ER mutation
Estrogen Receptor Positive Breast Cancer
palbociclib
Sensitive
:
B
ER mutation
Breast Cancer
palbociclib
Resistant
:
B
ER mutation
Hormone Receptor Positive Breast Cancer
exemestane
Resistant
:
B
ER mutation
Estrogen Receptor Positive Breast Cancer
fulvestrant
Sensitive
:
B
ER mutation
Estrogen Receptor Positive Breast Cancer
exemestane
Resistant
:
B
ER mutation
Hormone Receptor Positive Breast Cancer
fulvestrant
Sensitive
:
B
ER mutation
HER2 Negative Breast Cancer
Aromatase inhibitor + palbociclib
Resistant
:
B
ER mutation
Breast Cancer
fulvestrant
Sensitive
:
C2
ER mutation
HER2 Negative Breast Cancer
palbociclib + PF-05212384
Sensitive
:
C3
ER mutation
Breast Cancer
venetoclax
Sensitive
:
C3
ER mutation
Estrogen Receptor Positive Breast Cancer
enobosarm
Sensitive
:
C3
ER mutation
HER2 Negative Breast Cancer
SAR439859
Sensitive
:
C3
ER mutation
HER2 Negative Breast Cancer
CDK6 inhibitor
Resistant
:
C3
ER mutation
HER2 Negative Breast Cancer
CDK4 inhibitor
Resistant
:
C3
ER mutation
Hormone Receptor Positive Breast Cancer
alpelisib
Resistant
:
C3
ER mutation
HER2 Negative Breast Cancer
RAD1901
Sensitive
:
C3
ER mutation
HER2 Negative Breast Cancer
G1T48
Sensitive
:
C4
ER mutation
Estrogen Receptor Positive Breast Cancer
RAD1901
Sensitive
:
D
VERI is free for non-commercial use, no login needed.
Content on this site is for research purposes only and is not intended  to be a substitute for medical advice.
For commercial access, including additional premium features, please contact us.
By using VERI, you are agreeing to our